Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM)
同伴参与通过应急管理减少甲基苯丙胺危害 (PEER-CM)
基本信息
- 批准号:10590236
- 负责人:
- 金额:$ 193.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:AchievementAgeBehaviorCOVID-19 pandemicCaringClientCollaborationsCommunitiesContingency FundCountyDrug usageEffectivenessEvidence based interventionFentanylFundingGoalsHarm ReductionHealthHybridsIncentivesInterventionInterviewKnowledgeLifeMethamphetamineMethamphetamine overdoseModelingNaloxoneOregonOverdoseOverdose reductionParticipantPersonsPharmaceutical PreparationsPoliciesProcessRandomizedRecovery SupportReportingRewardsRiskRuralSamplingServicesSiteSocial supportSpecialistStructureSubstance Use DisorderSyringesTestingTimeTrainingUnited StatesVisitWorkauthoritybasecontingency managementdesignevidence baseimplementation facilitatorsimplementation frameworkimplementation strategyimprovedinnovationmeetingsmethamphetamine useopioid useoutreach programoverdose deathpatient orientedpeerpeer networkspreventprogramspsychostimulantrural settingscale upstandard of carestemstimulant usetest striptreatment comparisontreatment servicestrendurban setting
项目摘要
Project Summary/Abstract
Use of fentanyl and methamphetamine (MA) made 2021 the deadliest year ever for people using drugs in the
United States (US). Intentional co-use as well as rising adulteration of MA with fentanyl elevate the risks and
harms associated with MA use – the age-adjusted rate of drug overdose deaths involving psychostimulants
(primarily MA) increased 10-fold between 2009 and 2019. Little is known about preventing overdoses involving
MA or engaging people using MA in harm reduction and treatment. Strategies to engage people who use MA
in harm reduction activities are essential. Contingency management (CM) uses rewards to incentivize
behaviors and is the most efficacious strategy for improved retention in treatment and reduced stimulant use.
Peer recovery support specialists reach people not seeking treatment to help them identify harm reduction
goals and engage in treatment. The PEER-CM study combines both evidence-based interventions—CM and
peer engagement--to decrease overdose and improve engagement in harm reduction services for people who
use MA. Our network of peer harm reduction organizations is eager to identify optimal strategies for
implementing Oregon’s recent approval of sustainable CM funding to reduce overdose. The PEER-CM study
tests the effect of incentivizing achievement of self-identified, personal harm reduction goals compared with
standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and
effectiveness of MA harm reduction services. A hybrid type 1 effectiveness-implementation framework and
stepped-wedge design randomizes eighteen community-based peer harm reduction sites to provide standard
of care (incentives for peer encounters) versus client achievement of self-identified, personal harm reduction
goals. Peers assist clients in setting personal harm reduction goals using a client-driven harm reduction goal-
setting process focused on completing harm reduction supply training, possessing harm reduction supplies,
daily life goals, treatment and care goals, and relationship and social support goals. The CM intervention is
rolled out at three-month intervals in the stepped-wedge design (2 peer sites at a time). Peers manage
incentives and facilitate progress towards meeting self-identified goals. Aim 1 tests the impact of incentives for
achieving self-identified, personal harm reduction goals on the likelihood of overdose among people using MA.
Aim 2 determines whether incentives for achieving self-identified, personal harm reduction goals increase
engagement with harm reduction and treatment services. Aim 3 completes qualitative interviews to understand
the optimal context and implementation strategies for peer-facilitated contingency management. The PEER-
CM study advances a patient-centered, sustainable, scalable, and innovative contingency management model
to increase the impact of harm reduction delivered outside of traditional treatment networks and stem the tide
of overdose among people who use MA. The collaboration with the Oregon Health Authority’s peer initiative
facilitates policy change and sustainable services well beyond the proposed work.
项目总结/摘要
芬太尼和甲基苯丙胺(MA)的使用使2021年成为美国吸毒者有史以来最致命的一年。
United States(US).有意的共同使用以及越来越多的MA与芬太尼的掺假增加了风险,
与MA使用相关的危害-涉及精神兴奋剂的药物过量死亡的年龄调整率
(主要是MA)在2009年至2019年期间增加了10倍。关于预防过量用药知之甚少,
MA或让使用MA的人参与减少伤害和治疗。吸引使用MA的人的策略
在减少危害活动中至关重要。应急管理(CM)使用奖励来激励
行为,是改善治疗保留和减少兴奋剂使用的最有效策略。
同伴康复支持专家接触不寻求治疗的人,帮助他们确定减少伤害
目标并参与治疗。PEER-CM研究结合了循证干预-CM和
同伴参与--减少吸毒过量并改善人们对减少伤害服务的参与
使用MA。我们的减少同伴伤害组织网络渴望确定最佳策略,
实施俄勒冈州最近批准的可持续CM资金,以减少过量。PEER-CM研究
测试激励实现自我确定的个人伤害减少目标的效果,
护理标准(减少同伴伤害服务,鼓励同伴探视),以扩大覆盖面,
降低MA危害服务的有效性。混合型第1类有效性-执行框架,
阶梯楔形设计随机抽取了18个社区为基础的减少同伴伤害网站,
护理(同伴接触的激励措施)与客户实现自我识别,个人伤害减少
目标.同行协助客户使用客户驱动的伤害减少目标来设定个人伤害减少目标-
设定过程的重点是完成减少危害用品培训,拥有减少危害用品,
日常生活目标,治疗和护理目标,以及关系和社会支持目标。CM干预是
在阶梯楔形设计中每隔三个月推出一次(每次2个对等站点)。同行管理
鼓励和促进实现自我确定的目标。目标1测试激励措施的影响,
在使用MA的人群中实现自我确定的减少个人伤害的目标。
目标2决定了实现自我确定的个人伤害减少目标的激励是否增加
参与减少伤害和治疗服务。目标3完成定性访谈,以了解
同行促进的应急管理的最佳背景和实施战略。同行-
CM研究推进了以患者为中心的,可持续的,可扩展的和创新的应急管理模式
在传统治疗网络之外增加减少危害的影响,
使用MA的人中过量使用。与俄勒冈州卫生局的同行倡议合作
促进政策变化和可持续服务远远超出拟议的工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip Todd Korthuis其他文献
Philip Todd Korthuis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip Todd Korthuis', 18)}}的其他基金
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
在农村研究中基于同伴的吸毒者保留 (PROUD-R2)
- 批准号:
10238785 - 财政年份:2018
- 资助金额:
$ 193.64万 - 项目类别:
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
在农村研究中基于同伴的吸毒者保留 (PROUD-R2)
- 批准号:
10468109 - 财政年份:2018
- 资助金额:
$ 193.64万 - 项目类别:
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
在农村研究中基于同伴的吸毒者保留 (PROUD-R2)
- 批准号:
10011950 - 财政年份:2018
- 资助金额:
$ 193.64万 - 项目类别:
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study
俄勒冈州艾滋病毒/肝炎和阿片类药物预防和参与 (OR-HOPE) 研究
- 批准号:
10241487 - 财政年份:2017
- 资助金额:
$ 193.64万 - 项目类别:
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost Extension
俄勒冈州艾滋病毒/肝炎和阿片类药物预防和参与 (OR-HOPE) 研究费用延期
- 批准号:
10646953 - 财政年份:2017
- 资助金额:
$ 193.64万 - 项目类别:
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study
俄勒冈州艾滋病毒/肝炎和阿片类药物预防和参与 (OR-HOPE) 研究
- 批准号:
9760226 - 财政年份:2017
- 资助金额:
$ 193.64万 - 项目类别:
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study
俄勒冈州艾滋病毒/肝炎和阿片类药物预防和参与 (OR-HOPE) 研究
- 批准号:
9412025 - 财政年份:2017
- 资助金额:
$ 193.64万 - 项目类别:
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial
丁丙诺啡改善艾滋病毒护理参与度和结果:随机试验
- 批准号:
8733147 - 财政年份:2013
- 资助金额:
$ 193.64万 - 项目类别:
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial
丁丙诺啡改善艾滋病毒护理参与度和结果:随机试验
- 批准号:
8851556 - 财政年份:2013
- 资助金额:
$ 193.64万 - 项目类别:
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial
丁丙诺啡改善艾滋病毒护理参与度和结果:随机试验
- 批准号:
8667620 - 财政年份:2013
- 资助金额:
$ 193.64万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Conference: Biology in the Age of Gene Editing: New Tools and Novel Insights into Organismal Biology and the Neural Basis of Behavior
会议:基因编辑时代的生物学:对有机体生物学和行为神经基础的新工具和新见解
- 批准号:
2223926 - 财政年份:2022
- 资助金额:
$ 193.64万 - 项目类别:
Standard Grant
Developing and Validating the Diffusion Mechanism of Content Sharing Behavior in the Age of Social Networks
开发并验证社交网络时代内容共享行为的扩散机制
- 批准号:
21K01757 - 财政年份:2021
- 资助金额:
$ 193.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expanding Mentorship and Neuroimaging Expertise in Patient-Oriented Studies of Brain, Behavior, and Age-Related Dementias
扩大以患者为中心的大脑、行为和年龄相关痴呆症研究的指导和神经影像专业知识
- 批准号:
10403568 - 财政年份:2020
- 资助金额:
$ 193.64万 - 项目类别:
Expanding Mentorship and Neuroimaging Expertise in Patient-Oriented Studies of Brain, Behavior, and Age-Related Dementias
扩大以患者为中心的大脑、行为和年龄相关痴呆症研究的指导和神经影像专业知识
- 批准号:
10636842 - 财政年份:2020
- 资助金额:
$ 193.64万 - 项目类别:
Expanding Mentorship and Neuroimaging Expertise in Patient-Oriented Studies of Brain, Behavior, and Age-Related Dementias
扩大以患者为中心的大脑、行为和年龄相关痴呆症研究的指导和神经影像专业知识
- 批准号:
10259768 - 财政年份:2020
- 资助金额:
$ 193.64万 - 项目类别:
Expanding Mentorship and Neuroimaging Expertise in Patient-Oriented Studies of Brain, Behavior, and Age-Related Dementias
扩大以患者为中心的大脑、行为和年龄相关痴呆症研究的指导和神经影像专业知识
- 批准号:
10055550 - 财政年份:2020
- 资助金额:
$ 193.64万 - 项目类别:
Behavior and function of dissolved organic matter in the northwestern Pacific Ocean discovered by radiocarbon age
放射性碳年龄发现西北太平洋溶解有机物的行为和功能
- 批准号:
19H04260 - 财政年份:2019
- 资助金额:
$ 193.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Can Behavior Shape Neural Health? Identifying Modifiable Factors to Prevent Cognitive Decline in Age
行为可以塑造神经健康吗?
- 批准号:
9924492 - 财政年份:2018
- 资助金额:
$ 193.64万 - 项目类别:
Factors and developmental significance that determine the interpretation of playfulness and teasing behavior from infancy to school age
决定从婴儿期到学龄期玩耍和戏弄行为的解释的因素和发展意义
- 批准号:
18K02443 - 财政年份:2018
- 资助金额:
$ 193.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Can Behavior Shape Neural Health? Identifying Modifiable Factors to Prevent Cognitive Decline in Age
行为可以塑造神经健康吗?
- 批准号:
10368146 - 财政年份:2018
- 资助金额:
$ 193.64万 - 项目类别: